Trials / Completed
CompletedNCT02387554
Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405
A Randomized, Open-label, 4-way Crossover Single Dose Clinical Trial to Investigate the Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405 When Administered Alone and in Combination in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the pharmacokinetic interaction and safety between HGP0904, HGP0608 and HGP1405 when administered alone and in combination in healthy male volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HGP0904 | |
| DRUG | HGP0608 | |
| DRUG | HGP1405 |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2015-03-13
- Last updated
- 2015-06-12
- Results posted
- 2015-06-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02387554. Inclusion in this directory is not an endorsement.